Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial…
<!-- Name:DistributionId Value:8744827 -->
<!--…
Read More...
Read More...
Browsing Tag
CD19
GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific…
Ongoing experiments will evaluate the functionality and efficacy of GTB-7550 in vivoFuture studies will also involve…
Read More...
Read More...
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted…
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a…
Read More...
Read More...
Athenex 在第 63 屆 ASH 年會和博覽會上公佈了 KUR-502（同種異體 CD19 CAR-NKT 細胞）治療復發或難治淋巴瘤和白血病的 ANCHOR 研究中期數據
5 名患者的結果顯示最佳反應為 2 人部分緩解 (PR)、1 人完全緩解但血液學恢復不完全 (CRi) 和 1 人完全緩解 (CR)。 更新的數據顯示，在接受低劑量 KUR-502…
Read More...
Read More...